The role of S.aureus cell wall structure during host:pathogen interaction
The role of S.aureus cell wall structure during host:pathogen interaction
批准号:
1812138
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
S.金黄色葡萄球菌是一种主要的耐抗生素的人类病原体。针对细菌细胞壁,通过抗生素如β-内酰胺类抗生素合成肽聚糖(PG)已成为我们对抗S.金黄色。PG也被宿主识别,并参与休克,关节炎等,尽管这一重要性,我们不知道感染期间的PG的结构,阻碍了技术困难,在获得足够的材料。传染病的跨学科项目将跨越从单个分子到整个动物的长度尺度,结合宿主:病原体相互作用,分子成像和生物化学来定义感染期间的第一个PG结构以及特定体内产生的结构在疾病中的作用。科学目标:1。肽聚糖的体外制备及结构分析将使用在富培养基中体外生长的细菌并在模拟体内条件(全血)的条件下测定金黄色葡萄球菌PG。反相高效液相色谱法分离多肽,结合质谱和核磁共振将确定S的结构和修饰。aureus PG(纽卡斯尔和谢菲尔德)。将使用在谢菲尔德开发的方案测量聚糖链长度。原子力显微镜将决定PG架构。对检测灵敏度的分析将确定所需的细菌数量(对于体内分析很重要)。2.肽聚糖修饰在宿主与病原体相互作用中的作用分析学生将接受S.金黄色葡萄球菌感染,使用我们完善的小鼠模型。这需要内政部的个人许可证。然后学生将使用小鼠脓毒症模型,该模型的主要细菌输出是器官中的细菌。所有与细菌相关的细菌都是在体内生长的,因为每一种细菌都是由一种单独的细菌建立的。脓肿可含有高达109 cfu,初步数据表明这足以进行分析。已经建立了从粪便中收获细菌的方案。将纯化PG,并将其结构和架构与体外衍生材料进行比较。3.分析PG修饰在宿主与病原体相互作用中的作用。金黄色葡萄球菌基因突变体,如PG水解酶、O-乙酰转移酶etc.is可获得)。已知修饰如0-乙酰化在宿主:病原体相互作用中具有重要作用。PG结构具有多种功能,将进行测试,包括通过酶抵抗宿主攻击和脱落物质对免疫系统的影响(细胞因子分析等)。4.抗生素耐药性和治疗对PG体内结构的影响金黄色葡萄球菌(MRSA)是一个主要的医疗保健问题。甲氧西林和其他β-内酰胺类药物的靶点是PG的生物合成。MRSA PG的体内结构以及抗生素如何影响它尚不清楚。如果我们要确定新的治疗方案,重要的是要确定现有的阻力模式如何防止有效的控制。
英文摘要
S. aureus is a major, antibiotic resistant, human pathogen. Targeting bacterial cell wall, peptidoglycan (PG) biosynthesis via antibiotics such as the beta-lactams has been a crucial part in our fight against S. aureus. PG is also recognized by the host, and is involved in shock, arthritis etc. Despite this importance we do not know the structure of the PG during infection, hampered by technological difficulties in obtaining enough material. The interdisciplinary project, in infectious disease will span the length scales from single molecules to whole animals, combining host:pathogen interaction, molecular imaging and biochemistry to define the first PG structure during infection and the role of specific in vivo produced structures in disease. Scientific Objectives:1. Production and analysis of peptidoglycan structure in vitroThe structure of S. aureus PG will be determined using bacteria grown in vitro in rich media and under conditions that mimic in vivo conditions (whole human blood). RP-HPLC separation of muropeptides, coupled with MS and NMR will define the structure and modification of S. aureus PG (Newcastle and Sheffield). Glycan strand length will be measured using a protocol developed in Sheffield. Atomic force microscopy will determine PG architecture. Analysis of the sensitivity of the assays will determine the number of bacteria required (important for the in vivo analysis). 2. Analysis of the role of modification of peptidoglycan during host:pathogen interactionThe student will be trained in in vivo analysis of S. aureus infection, using our well-established mouse models. This requires a Home Office personal licence. The student will then use the mouse sepsis model, a primary bacterial output of the model being abscesses in organs. All the abscess-associated bacteria have grown in vivo as each is founded by an individual bacterium. Abscesses can contain up to 109 cfu, which preliminary data suggests is enough PG for analysis. A protocol has already been established for harvesting bacteria from abscesses. PG will be purified and its structure and architecture compared to in vitro derived material. 3. Analysis of the role of PG modifications in host:pathogen interaction.The importance of in vivo associated cell wall features will be tested by the use of specific mutants (an ordered library of S. aureus mutants in genes such as PG hydrolases, O-acetyltransferase etc.is available). It is known that modifications such as O-acetylation have an important role in host:pathogen interaction. PG structure has multiple functions that will be tested including resistance to host attack via enzymes and the effect of shed material on the immune system (cytokine analysis etc). 4. Role of antibiotic resistance and treatment on PG in vivo structureMethicillin Resistant S. aureus (MRSA) is a major healthcare problem. The target of methicillin and other beta-lactams is PG biosynthesis. The in vivo structure of MRSA PG and how antibiotics effect this is unknown. If we are to identify new treatment regimes it is important to determine how existing resistance modalities prevent effective control.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
circRNA_13977在S.aureus型奶牛乳房炎中的作用及分子调控机制
-
批准号:32460826
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2024
-
负责人:罗仍卓么
-
依托单位:
1,3-β-葡聚糖抑制自噬调控S.aureus胞内感染奶牛乳腺上皮细胞的作用及机制研究
-
批准号:32402961
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:代宏宇
-
依托单位:
NIR-II荧光活体成像动态解析关节植入物S.aureus感染时空演变及与巨噬细胞免疫平衡机制的研究
-
批准号:82302787
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:冯思嘉
-
依托单位:
NETs/EVs/cGAS-STING在S.aureus感染引起的乳腺炎中的作用机制研究
-
批准号:32302945
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:马娜娜
-
依托单位:
S.aureus DC15群体感应信号分子AIP新型受体蛋白及调控生物膜形成分子机制
-
批准号:32302259
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:施娅楠
-
依托单位:
非编码RNA介导等离子体胁迫对S.aureus产生交叉适应的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2022
-
负责人:丁甜
-
依托单位:
PINK1/Parkin线粒体自噬对S.aureus诱导的奶牛乳腺上皮细胞炎症的影响及硒的调控机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:
-
依托单位:
补体C3在S.aureus诱导鼠巨噬细胞分泌IL-1β中的作用及其机制研究
-
批准号:32072826
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:吴文学
-
依托单位:
基于组学技术的辣木籽肽MOp2对S.aureus的抑菌机制研究
-
批准号:31960462
-
项目类别:地区科学基金项目
-
资助金额:40.0万元
-
批准年份:2019
-
负责人:王雪峰
-
依托单位:
等离子体中活性含氧/氮基团对S.aureus生物膜再生特性的作用机制研究
-
批准号:51807046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:许子牧
-
依托单位: